Pursuant to the provisions of Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Aarti Drugs has informed that the officials of the Company will be attending the Investor Conference on 28th February 2023 organised by Goldman Sachs (India) Securities. The copy of Investor Presentation – December 2022 to be shared with participants has already been uploaded on stock exchanges and is also available on the website of the Company at www.aartidrugs.co.in. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
The above information is a part of company’s filings submitted to BSE.
